Published in
Elsevier, International Journal of Pharmaceutics, 1-2(506), p. 268-279
DOI: 10.1016/j.ijpharm.2016.04.031
Links
Tools
Aptamer targeting of the elongation factor 1A impairs hepatocarcinoma cells viability and potentiates bortezomib and idarubicin effects
Journal article published in 2016 by
Bruna Scaggiante 
,
Rosella Farra,
Barbara Dapas,
Gabriele Baj,
Gabriele Pozzato,
Mario Grassi,
Fabrizio Zanconati,
Gabriele Grassi
,
Rosella Farra,
Barbara Dapas,
Gabriele Baj,
Gabriele Pozzato,
Mario Grassi,
Fabrizio Zanconati,
Gabriele Grassi
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Postprint:
archiving forbidden
Published version:
archiving forbidden
Data provided by 